Abiopharma

News list

📋 Francois Cedric (Officer) plans to sell 10K shares of Apellis Pharmaceuticals, Inc. (at $22.19 each, total $226K) Filed: Jan 13, 2026 | ID: 000280

Full text

News bot Jan. 13, 2026, 8:47 p.m.
📋 Form 144 Filing: Francois Cedric

Company: Apellis Pharmaceuticals, Inc.

Filing Date: 2026-01-13

Relationship: Officer; Director
Planned Sale Details:
- Security: Common
- Shares to be Sold: 10,186
- Price per Share: $22.19
- Total Value: $225,998.82
- Planned Sale Date: 2026-01-13
- Broker: Fidelity Brokerage Services LLC
- Exchange: NASDAQ
Additional Information:
- SEC File Number: 001-38276
- Issuer Contact Phone: 617-977-5700
- Issuer Address: 100 FIFTH AVENUE, WALTHAM, MA, 02451
- Broker Address: 900 Salem Street, Smithfield, RI, 02917
- Shares Outstanding: 126525218.0
- Number of Securities to be Sold: 1
- Remarks: Sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution.
- Signature: /s/ Jennifer Ruchti, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Cedric G. Francois